What is the recommended initial treatment for a patient presenting with hypertensive urgency in the ED setting, considering factors such as race and potential comorbidities like kidney disease or heart failure?

Management of Hypertensive Urgency in the Emergency Department

Direct Recommendation

Patients with hypertensive urgency (severely elevated BP without acute end-organ damage) should be treated with oral antihypertensive agents and can typically be discharged after a brief observation period, rather than receiving IV medications or hospital admission. 1

---

Distinguishing Urgency from Emergency

The critical first step is determining whether acute hypertension-mediated organ damage exists:

• Hypertensive urgency: Severe BP elevation (typically >180/120 mmHg) WITHOUT progressive target organ dysfunction 1

  • Examples: severe headache, shortness of breath, epistaxis, severe anxiety 1
  • These patients do NOT require immediate BP reduction or ICU admission 1

• Hypertensive emergency: Severe BP elevation WITH evidence of acute organ damage to heart, retina, brain, kidneys, or large arteries 1

  • Examples: malignant hypertension with retinopathy, acute renal failure, hypertensive encephalopathy, acute MI, acute heart failure, aortic dissection, stroke 1
  • These patients require immediate IV therapy and ICU admission 1

Essential diagnostic workup for suspected hypertensive urgency includes: fundoscopy (looking for hemorrhages, cotton wool spots, papilledema), urinalysis for protein and sediment, serum creatinine, hemoglobin, platelets, LDH, haptoglobin, and ECG to rule out occult end-organ damage 1

---

Treatment Approach for Hypertensive Urgency

Oral Medication Strategy

For hypertensive urgency, initiate oral antihypertensive therapy with gradual BP reduction over 24-48 hours 1, 2:

• Target: Reduce BP by 20-25% over 24-48 hours, NOT to normal immediately 1, 2
• Avoid: Rapid BP reduction, which can precipitate renal, cerebral, or coronary ischemia 1
• Short-acting nifedipine is NO LONGER acceptable for hypertensive urgencies due to unpredictable hypotensive effects 1

Medication Selection Based on Patient Characteristics

For patients WITHOUT specific comorbidities:

• Start with a calcium channel blocker (amlodipine 5-10mg) OR an ACE inhibitor/ARB (lisinopril 10-20mg or losartan 50mg) 3
• Alternative: thiazide-like diuretic (chlorthalidone 12.5-25mg) 3

For Black patients with hypertensive urgency:

• Prefer calcium channel blocker (amlodipine 5-10mg) OR thiazide diuretic as initial therapy 4, 5
• If kidney disease or heart failure coexists, use combination therapy from the outset: ARB (losartan 50mg) PLUS calcium channel blocker (amlodipine 5mg) 4
• Black patients require combination therapy from the start when diabetes and renal impairment coexist, as monotherapy is insufficient 4

For patients with chronic kidney disease or diabetic nephropathy:

• ACE inhibitor or ARB is the foundation of therapy due to renoprotective benefits 4
• Combination with calcium channel blocker or thiazide diuretic is typically needed 4
• Target BP <130/80 mmHg in these high-risk patients 4

For patients with heart failure:

• ACE inhibitor/ARB PLUS diuretic 4
• Avoid non-dihydropyridine calcium channel blockers (diltiazem, verapamil) due to negative inotropic effects 5

---

Disposition and Follow-up

After initiating oral therapy in the ED 1, 3:

• Observe for 1-2 hours to ensure BP begins trending downward
• Reassess for development of symptoms suggesting organ damage
• Most patients can be safely discharged with close outpatient follow-up within 24-72 hours 1
• Provide clear instructions about medication adherence and warning signs requiring immediate return

Target BP goals 1, 4:

• Initial: <160/100 mmHg before discharge
• Outpatient: <140/90 mmHg minimum, ideally <130/80 mmHg for high-risk patients
• Achieve target within 3 months of treatment initiation 4

---

Critical Pitfalls to Avoid

Do NOT treat hypertensive urgency like an emergency 1:

• Avoid IV medications in the absence of acute organ damage
• Avoid rapid BP reduction, which increases risk of stroke, MI, and acute kidney injury 1
• Aggressive BP lowering in urgencies can cause more harm than benefit 2

Do NOT use short-acting nifedipine 1:

• Associated with unpredictable hypotensive effects and ischemic complications
• No longer considered acceptable for hypertensive urgencies 1

Do NOT admit patients with urgency to the hospital 1:

• Admission is reserved for hypertensive emergencies with documented organ damage
• Unnecessary admissions increase healthcare costs without improving outcomes 1

Do NOT combine ACE inhibitor with ARB 4, 5:

• Dual RAS blockade increases adverse events (hyperkalemia, acute kidney injury) without cardiovascular benefit 4

Do NOT ignore secondary causes 1:

• 20-40% of patients with severe hypertension have secondary causes (renal artery stenosis, primary aldosteronism, medication non-adherence) 1
• Screen for interfering medications: NSAIDs, decongestants, sympathomimetics, cocaine 1

Do NOT use monotherapy in high-risk patients 4:

• Patients with diabetes, chronic kidney disease, Black race, or heart failure typically require combination therapy from the outset 4

---

Special Considerations

For patients with suspected non-adherence (the most common presentation) 1:

• Address barriers to medication access (cost, side effects, complexity) 1
• Simplify regimen with single-pill combinations when possible 4
• Arrange rapid outpatient follow-up to ensure adherence 3

Lifestyle modifications should be emphasized 4:

• Sodium restriction to <2g/day (provides 5-10 mmHg reduction) 4
• Weight loss if overweight 4
• Alcohol limitation to <100g/week 4